Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation
摘要:
Inhibition of the PHD2 enzyme has been associated with increased red blood cell levels. From a screening hit, a series of novel hydroxyl-thiazoles were developed as potent PHD2 inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.
Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation
作者:Christopher M. Tegley、Vellarkad N. Viswanadhan、Kaustav Biswas、Michael J. Frohn、Tanya A.N. Peterkin、Catherine Chang、Roland W. Bürli、Jennifer H. Dao、Henrike Veith、Norma Rogers、Sean C. Yoder、Gloria Biddlecome、Philip Tagari、Jennifer R. Allen、Randall W. Hungate
DOI:10.1016/j.bmcl.2008.06.031
日期:2008.7
Inhibition of the PHD2 enzyme has been associated with increased red blood cell levels. From a screening hit, a series of novel hydroxyl-thiazoles were developed as potent PHD2 inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.